immunoglobulin-linked interferon-alpha

a recombinant human interferon-alpha (rhIFN-alpha) linked to immunoglobulin via N-terminal-specific non-peptidyl polyethylene glycol linker to improve the in vivo stability of interferon

Also Known As:

interferon-alpha, immunoglobulin-linked; HM10620

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
- Peptides: 82426
  - Intercellular Signaling Peptides and Proteins: 29768
    - Cytokines: 164289
      - Interferons: 39171
        Interferon Type I: 4788
        Interferon-alpha: 11740
        immunoglobulin-linked interferon-alpha: 1
Biological Factors: 2472
- Intercellular Signaling Peptides and Proteins: 29768
  - Cytokines: 164289
    - Interferons: 39171
      - Interferon Type I: 4788
        Interferon-alpha: 11740
        immunoglobulin-linked interferon-alpha: 1

Experts

1.	Choi, In Young: 1 article (01/2007)
2.	Han, Jae Yong: 1 article (01/2007)
3.	Kim, Choong-Yong: 1 article (01/2007)
4.	Kim, Ji-Young: 1 article (01/2007)
5.	Koh, Woo Suk: 1 article (01/2007)
6.	Kwon, Se Chang: 1 article (01/2007)
7.	Lee, Gwan Sun: 1 article (01/2007)
8.	Lee, Michael: 1 article (01/2007)
9.	Lee, Young-Mi: 1 article (01/2007)

Related Diseases

1.	Chromosome Aberrations (Chromosome Abnormalities) 01/01/2007 - "Potential genotoxic effects of HM10620 in three short-term mutagenicity assays were investigated, which included the Ames assay, in vitro chromosomal aberration assay, and the in vivo micronucleus assay. "